Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,468 | 6,044 | 7,524 | 8,621 | 2,752 |
| Receivables | 644 | 768 | 914 | 1,078 | N/A |
| TOTAL | $8,281 | $7,013 | $8,533 | $9,868 | $2,943 |
| Non-Current Assets | |||||
| PPE Net | 431 | 459 | 368 | 386 | 384 |
| Intangibles | 19,092 | 65,195 | 65,195 | 65,195 | 65,195 |
| Other Non-Current Assets | 727 | 770 | 811 | 842 | 40 |
| TOTAL | $20,250 | $66,424 | $66,374 | $66,423 | $65,619 |
| Total Assets | $28,531 | $73,437 | $74,907 | $76,291 | $68,562 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,999 | 1,690 | 1,361 | 1,211 | 1,080 |
| Other current liabilities | 7 | 90 | 123 | 163 | 263 |
| TOTAL | $2,286 | $2,105 | $1,854 | $1,753 | $1,557 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 523 | 569 | 614 | 657 | 0 |
| TOTAL | $537 | $587 | $635 | $718 | $117 |
| Total Liabilities | $2,823 | $2,692 | $2,489 | $2,471 | $1,674 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,343 | 2,928 | 2,634 | 2,634 | 2,634 |
| Common Shares | 36 | 32 | 32 | 32 | 30 |
| Retained earnings | -235,260 | -187,415 | -185,635 | -184,120 | -187,091 |
| TOTAL | $25,708 | $70,745 | $72,418 | $73,820 | $66,888 |
| Total Liabilities And Equity | $28,531 | $73,437 | $74,907 | $76,291 | $68,562 |